ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
0.00%
US Dollar vs MXN
16.53692
-0.11%
Brent Oil
82.26
-1.52%
Bitcoin
71,357.93
-0.13%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. InVivo Therapeutics Holdings Corporation (NVIV)

  7. InVivo Therapeutics Holdings Corporation (NVIV) Noticias

NVIV

InVivo Therapeutics (NVIV)

InVivo Therapeutics Holdings Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NVIV
FechaHoraFuenteTítuloSímboloCompañía
21/03/202413:23Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/02/202413:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202413:12Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/02/202412:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/02/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
05/12/202307:35Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
05/12/202307:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/11/202315:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
12/05/202315:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
25/04/202316:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/03/202308:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/03/202307:55Business WireInVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord InjuryNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
01/03/202315:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
22/11/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
21/11/202216:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/11/202205:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/11/202216:26Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/10/202215:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/10/202215:01Business WireInVivo Therapeutics Announces Closing of $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/10/202210:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
07/10/202207:00Business WireInVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq RulesNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
09/09/202207:00Business WireInVivo Therapeutics Announces Participation at Upcoming H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
06/09/202205:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
18/08/202208:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
11/08/202215:03Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
13/07/202207:30Business WireInVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General CounselNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/07/202215:32Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:NVIVInVivo Therapeutics Holdings Corporation
08/06/202207:30Business WireInVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed NeurosurgeryNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
02/06/202207:30Business WireInVivo Therapeutics Announces Completion of Enrollment for the INSPIRE 2.0 Acute Spinal Cord Injury StudyNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
14/04/202215:30Business WireInVivo Therapeutics Announces Reverse Stock SplitNASDAQ:NVIVInVivo Therapeutics Holdings Corporation
 Showing the most relevant articles for your search:NASDAQ:NVIV

Su Consulta Reciente

NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
USOTC
BASFY
BASF (QX)
NYSE
MCD
McDonalds
FX
USDMXN
US Dollar vs MXN
CCOM
US30
US 30
NYSE
VZ
Verizon Communications
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
NYSE
XOM
Exxon Mobil
USOTC
RHHBY
Roche (QX)
NYSE
AXP
American Express
AMEX
XLF
Financial Select Sector
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados